Showing results (101-110 of 182) with videos related to
Sort By:
Pageof 19
Frontiers in Immunology|May 16, 2022
Secondary Complement Deficiency Impairs Anti-Microbial Immunity to Klebsiella pneumoniae and Staphylococcus aureus During Severe Acute COVID-19Youssif M Ali, Nicholas J Lynch, Priyanka Khatri, et al.Immunogenetics|April 2, 2009
Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaquesEdward T Mee, Neil Berry, Claire Ham, et al.Nature Communications|May 20, 2015
Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistanceMahima Swamy, Lucie Abeler-Dörner, James Chettle, et al.Plos One|January 5, 2012
A viral discovery methodology for clinical biopsy samples utilising massively parallel next generation sequencingGordon M Daly, Nick Bexfield, Judith Heaney, et al.Vaccine|November 21, 2009
A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in AfricaEdward Wright, Suzanne McNabb, Trudy Goddard, et al.The Journal of Allergy and Clinical Immunology. Global|April 11, 2023
Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficienciesErnest T Aguinam, Angalee Nadesalingam, Andrew Chan, et al.European Journal of Immunology|March 23, 2010
CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infectionErik Rutjens, Stefania Mazza, Roberto Biassoni, et al.Plos One|August 23, 2013
Genetic imprint of vaccination on simian/human immunodeficiency virus type 1 transmitted viral genomes in rhesus macaquesMariana Varela, Ernst Verschoor, Rachel P J Lai, et al.The Journal of Infectious Diseases|April 1, 2011
Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infectionLorena Itatí Ibañez, Marina De Filette, Anna Hultberg, et al.Cell Host & Microbe|July 16, 2008
Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibilityWeijing He, Stuart Neil, Hemant Kulkarni, et al.Pageof 19